Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
By I. Wapnir, J. Dignam, B. Fisher, E. Mamounas, S. Anderson, T. Julian, S. Land, R. Margolese, S. Swain, J. Costantino and 1 more. Journal of the National Cancer Institute, 2011
779 citations recorded by the source corpus.
Subfields: Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/8ad7f0061e047790b8368557a46726f7e3a7e5a6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (2018, background): “The Panel acknowledged the recent trials showing that either aromatase inhibitors (AIs) or tamoxifen can be an effective adjuvant treatment options to lower the risk of recurrent DCIS [4, 5].”